Source:http://linkedlifedata.com/resource/pubmed/id/19601865
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2009-7-15
|
pubmed:abstractText |
Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide. Recently vitamin D deficiency has been identified as a potential risk factor for many diseases not traditionally associated with vitamin D, such as cancer and CVD. This review discusses the evidence suggesting an association between low 25-hydroxyvitamin D levels and CVD and the possible mechanisms mediating it. Vitamin D deficiency has been associated with CVD risk factors such as hypertension and diabetes mellitus, with markers of subclinical atherosclerosis such as intima-media thickness and coronary calcification as well as with cardiovascular events such as myocardial infarction and stroke as well as congestive heart failure. It could be suggested that vitamin D deficiency contributes to the development of CVD through its association with risk factors, such as diabetes and hypertension. However, direct effects of vitamin D on the cardiovascular system may also be involved. Vitamin D receptors are expressed in a variety of tissues, including cardiomyocytes, vascular smooth muscle cells and endothelial cells and vitamin D has been shown to affect inflammation and cell proliferation and differentiation. While much evidence supports a potential antiatherosclerotic effect of vitamin D, prospective, placebo-controlled randomized as well as mechanistic studies are needed to confirm this association. Since vitamin D deficiency is easy to screen for and treat, the confirmation of such an association could have important implications for both, patient care and health policy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1570-1611
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
414-22
|
pubmed:meshHeading |
pubmed-meshheading:19601865-Atherosclerosis,
pubmed-meshheading:19601865-Cardiovascular Diseases,
pubmed-meshheading:19601865-Clinical Trials as Topic,
pubmed-meshheading:19601865-Cohort Studies,
pubmed-meshheading:19601865-Diabetes Complications,
pubmed-meshheading:19601865-Humans,
pubmed-meshheading:19601865-Inflammation,
pubmed-meshheading:19601865-Polymorphism, Genetic,
pubmed-meshheading:19601865-Receptors, Calcitriol,
pubmed-meshheading:19601865-Risk Factors,
pubmed-meshheading:19601865-Vitamin D,
pubmed-meshheading:19601865-Vitamin D Deficiency,
pubmed-meshheading:19601865-Vitamin D-Binding Protein
|
pubmed:year |
2009
|
pubmed:articleTitle |
Vitamin D and cardiovascular disease.
|
pubmed:affiliation |
Department of Internal Medicine II, University of Cologne, D-50937 Cologne, Germany. ioanna.berthold@uni-koeln.de
|
pubmed:publicationType |
Journal Article,
Review
|